OBJECTIVE: The current study examined the association between diurnal cortisol profiles, inflammation, and functional limitations, among adults ranging in age from 34-84 years. METHOD: Participants (N = 799) completed Waves 2 (between 2004 and 2006) and 3 (between 2014 and 2016) of the Midlife Development in the United States Survey. At Wave 2, participants provided saliva samples across 4 consecutive days, from which cortisol was assayed. Previously validated diurnal cortisol profiles (i.e., normative, flattened, or elevated) were examined in relation to concurrent inflammation risk burden and to predict long-term changes in functional limitations. RESULTS: Compared with participants with normative profiles across all interview days, participants with dysregulated profiles across all interview days (i.e., all days elevated, flattened, or a combination of elevated and flattened) showed greater concurrent inflammation risk burden and more functional limitations at follow-up. Regions of significance testing indicated that the association was significant beginning at age 60 for inflammation risk burden and beginning at age 66 for functional limitations. Variable profiles (i.e., a mix of normative and flattened and/or elevated across the four days of assessment) were not significantly associated with these health indices. CONCLUSIONS: Findings, consistent with the theoretical model of Strength and Vulnerability Integration, illustrate the importance of considering age when examining cortisol and its association with other health indices. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
OBJECTIVE: The current study examined the association between diurnal cortisol profiles, inflammation, and functional limitations, among adults ranging in age from 34-84 years. METHOD:Participants (N = 799) completed Waves 2 (between 2004 and 2006) and 3 (between 2014 and 2016) of the Midlife Development in the United States Survey. At Wave 2, participants provided saliva samples across 4 consecutive days, from which cortisol was assayed. Previously validated diurnal cortisol profiles (i.e., normative, flattened, or elevated) were examined in relation to concurrent inflammation risk burden and to predict long-term changes in functional limitations. RESULTS: Compared with participants with normative profiles across all interview days, participants with dysregulated profiles across all interview days (i.e., all days elevated, flattened, or a combination of elevated and flattened) showed greater concurrent inflammation risk burden and more functional limitations at follow-up. Regions of significance testing indicated that the association was significant beginning at age 60 for inflammation risk burden and beginning at age 66 for functional limitations. Variable profiles (i.e., a mix of normative and flattened and/or elevated across the four days of assessment) were not significantly associated with these health indices. CONCLUSIONS: Findings, consistent with the theoretical model of Strength and Vulnerability Integration, illustrate the importance of considering age when examining cortisol and its association with other health indices. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
Authors: R M Reynolds; E M Dennison; B R Walker; H E Syddall; P J Wood; R Andrew; D Iw Phillips; C Cooper Journal: Calcif Tissue Int Date: 2005-09-08 Impact factor: 4.333
Authors: Timothy S Sannes; Susan K Mikulich-Gilbertson; Crystal L Natvig; Benjamin W Brewer; Teresa L Simoneau; Mark L Laudenslager Journal: Cancer Nurs Date: 2018 Jan/Feb Impact factor: 2.592
Authors: Henrik Oster; Etienne Challet; Volker Ott; Emanuela Arvat; E Ronald de Kloet; Derk-Jan Dijk; Stafford Lightman; Alexandros Vgontzas; Eve Van Cauter Journal: Endocr Rev Date: 2017-02-01 Impact factor: 19.871
Authors: Susan T Charles; Jacqueline Mogle; Jennifer R Piazza; Arun Karlamangla; David M Almeida Journal: Psychoneuroendocrinology Date: 2019-11-14 Impact factor: 4.905
Authors: Thomas E Fuller-Rowell; Olivia I Nichols; Markus Jokela; Eric S Kim; Elif Dede Yildirim; Carol D Ryff Journal: Am J Epidemiol Date: 2021-11-02 Impact factor: 4.897
Authors: Erik L Knight; Yanping Jiang; Jacqueline Rodriguez-Stanley; David M Almeida; Christopher G Engeland; Samuele Zilioli Journal: Brain Behav Immun Date: 2021-01-28 Impact factor: 7.217
Authors: Nathan M D'Cunha; Andrew J McKune; Stephen Isbel; Jane Kellett; Ekavi N Georgousopoulou; Nenad Naumovski Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472